Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Trujillo

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
The Annals of Pharmacotherapy|January 8, 2015
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetesAngela M Thompson, Jennifer M Trujillo
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 1, 2019
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump TherapyKali B Turrin, Jennifer M Trujillo
Therapeutic Advances in Chronic Disease|January 16, 2016
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulnessSarah L Anderson, Jennifer M Trujillo
The Annals of Pharmacotherapy|February 14, 2020
Intranasal Glucagon: A New Way to Treat Hypoglycemic EmergenciesRachel N Lowe, Jennifer M Trujillo
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen DevicesAnna Y Zhou, Jennifer M Trujillo
Pharmacotherapy|January 20, 2017
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 DiabetesJennifer M Trujillo, Wesley A Nuffer
The Annals of Pharmacotherapy|April 8, 2010
Association of pancreatitis with glucagon-like peptide-1 agonist useSarah L Anderson, Jennifer M Trujillo
Pharmacotherapy|October 27, 2015
Liraglutide: A New Option for the Treatment of ObesityWesley A Nuffer, Jennifer M Trujillo
Therapeutic Advances in Endocrinology and Metabolism|December 7, 2019
A review of sotagliflozin for use in type 1 diabetesWesley Nuffer, Briana Williams, Jennifer M Trujillo
The Annals of Pharmacotherapy|February 19, 2016
A Comparison of New Pharmacological Agents for the Treatment of ObesityWesley Nuffer, Jennifer M Trujillo, Jade Megyeri
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
The Annals of Pharmacotherapy|January 8, 2015
Dulaglutide: the newest GLP-1 receptor agonist for the management of type 2 diabetesAngela M Thompson, Jennifer M Trujillo
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|June 1, 2019
Effects of Diabetes Numeracy on Glycemic Control and Diabetes Self-Management Behaviors in Patients on Insulin Pump TherapyKali B Turrin, Jennifer M Trujillo
Therapeutic Advances in Chronic Disease|January 16, 2016
Lixisenatide in type 2 diabetes: latest evidence and clinical usefulnessSarah L Anderson, Jennifer M Trujillo
The Annals of Pharmacotherapy|February 14, 2020
Intranasal Glucagon: A New Way to Treat Hypoglycemic EmergenciesRachel N Lowe, Jennifer M Trujillo
Diabetes Spectrum : a Publication of the American Diabetes Association|December 5, 2018
Comparison of Usability, Accuracy, Preference, and Satisfaction Among Three Once-Weekly GLP-1 Receptor Agonist Pen DevicesAnna Y Zhou, Jennifer M Trujillo
Pharmacotherapy|January 20, 2017
Impact of Sodium-Glucose Cotransporter 2 Inhibitors on Nonglycemic Outcomes in Patients with Type 2 DiabetesJennifer M Trujillo, Wesley A Nuffer
The Annals of Pharmacotherapy|April 8, 2010
Association of pancreatitis with glucagon-like peptide-1 agonist useSarah L Anderson, Jennifer M Trujillo
Pharmacotherapy|October 27, 2015
Liraglutide: A New Option for the Treatment of ObesityWesley A Nuffer, Jennifer M Trujillo
Therapeutic Advances in Endocrinology and Metabolism|December 7, 2019
A review of sotagliflozin for use in type 1 diabetesWesley Nuffer, Briana Williams, Jennifer M Trujillo
The Annals of Pharmacotherapy|February 19, 2016
A Comparison of New Pharmacological Agents for the Treatment of ObesityWesley Nuffer, Jennifer M Trujillo, Jade Megyeri
Pageof 6